Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

Milestone Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT Virtual Conference


MONTREAL and CHARLOTTE, N.C., Jan. 4, 2022 /CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright BIOCONNECT Virtual Conference being held on January 10-13, 2022.

The prerecorded fireside chat will become available on Monday, January 10, 2022 at 7:00am ET and can be accessed in the News & Events section of Milestone's website at www.milestonepharma.com. An archived replay of the fireside chat will be available on the same website 90 days following the presentation.

About Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone's lead product candidate etripamil is currently in a Phase 3 clinical-stage program for the treatment of paroxysmal supraventricular tachycardia (PSVT) and in a Phase 2 proof-of-concept trial for the treatment of patients with atrial fibrillation and rapid ventricular rate (AFib-RVR). Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma.

Contact

David Pitts
Argot Partners
212-600-1902
[email protected]

(PRNewsfoto/Milestone Pharmaceuticals)

SOURCE Milestone Pharmaceuticals, Inc.


These press releases may also interest you

at 03:00
Recor Medical Champions Global Action on World Hypertension Day: Early Intervention and Continued Innovation Crucial in Tackling This Silent Killer Impacting Billions Worldwide
Hypertension, or high blood pressure, affects one in three Europeans over the age of 30 and more than one billion people worldwide.  Hypertension is known as the "silent killer" because many people do not know they have it and, over time, it can lead...

at 03:00
Flash News: OKX Adds Fusionist's ACE Token to On-Chain Earn Product
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for May 17, 2024. OKX Adds...

at 03:00
CUBE acquires global regulatory intelligence businesses from Thomson Reuters
CUBE, a global leader in Automated Regulatory Intelligence (ARI) and Regulatory Change Management (RCM), announces today its acquisition of the Thomson Reuters Regulatory Intelligence and Oden products and businesses. The acquisition of these global...

at 03:00
IIIF150 Air2 Ultra: World's Thinnest Rugged Phone at 8.55mm Thickness
Established in 2020, IIIF150 focuses on the premium ultra-thin rugged phones. Recognizing a common flaw in the current market ? the sacrifice of aesthetics and ergonomic design for durability ? IIIF150 product team set out to redefine the norm....

at 03:00
New Partnership Between Clean Cooking Alliance and World Resources Institute Seeks To Promote Clean Cooking in Key Regions
At the Summit on Clean Cooking in Africa, World Resources Institute (WRI) and the Clean Cooking Alliance (CCA) announced a strategic partnership to further embed clean cooking into a broad range of sustainable development initiatives across the two...

at 02:27
Kamux Corporation's Interim Report for January 1--March 31, 2024: Revenue grew and adjusted operating profit increased significantly, actions in Sweden are progressing
Kamux Corporation's Interim Report for January 1?March 31, 2024: Revenue grew and adjusted operating profit increased significantly, actions in Sweden are progressing This is a summary of Kamux Corporation's Interim Report for January 1?March 31,...

More news about Science and technology...


News published on and distributed by: